| Pliva Inc, with operations in more than 30 countries, is a wholly owned US subsidiary of Pliva Pharmaceuticals of Croatia. |
| Under the terms of the agreement, Pliva will fund certain development activity of Unichem, for conferring exclusivity to Pliva to market few of its generics under joint label in the US markets. |
| The development pact covers five products initially, which are in an advanced stage of development. |
| P A Mody, chairman and managing director, Unichem Laboratories, said that the company has now two partners to market its abbreviated new drug applications (ANDAs) in the US. |
| "We hope to build many more such mutually beneficial relationships for marketing our generics in the US markets, till we have a reasonable product basket to consider developing our own marketing team or an acquisition in th US". |
| The Rs 450 crore Unichem Laboratories currently develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. |
| It mainly produces and markets finished dosage formulations and active pharmaceutical ingredients in the therapeutic areas such as anti-infective, cardiovascular, psychiatry and neurology, musculo-skeletal, gastro-intestinal, nutritional, anti-allergic amongst others. |
| The company is also involved in research and development of new drug delivery systems (NDDS) and development of non-infringing process for active pharmaceutical ingredients. |
| While, Pliva is the leading company is recognised for its R&D excellence-and the discovery of its blockbuster antibiotic azithromycin, in particular. |
Top Section
Explore Business Standard